Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
about
Advances in the management of osteosarcomaEfficacy and safety of gemcitabine plus docetaxel in Japanese patients with unresectable or recurrent bone and soft tissue sarcoma: Results from a single-institutional analysisTreatment pathway of bone sarcoma in children, adolescents, and young adultsBMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation.Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS).Progress in the chemotherapeutic treatment of osteosarcoma
P2860
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of bone
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Gemcitabine and docetaxel in r ...... d spindle cell sarcoma of bone
@ast
Gemcitabine and docetaxel in r ...... d spindle cell sarcoma of bone
@en
type
label
Gemcitabine and docetaxel in r ...... d spindle cell sarcoma of bone
@ast
Gemcitabine and docetaxel in r ...... d spindle cell sarcoma of bone
@en
prefLabel
Gemcitabine and docetaxel in r ...... d spindle cell sarcoma of bone
@ast
Gemcitabine and docetaxel in r ...... d spindle cell sarcoma of bone
@en
P2093
P2860
P50
P1433
P1476
Gemcitabine and docetaxel in r ...... d spindle cell sarcoma of bone
@en
P2093
A Tamburini
E Marchesi
S M Pollack
P2860
P2888
P356
10.1186/S12885-016-2312-3
P407
P577
2016-04-20T00:00:00Z
P6179
1046613263